Atara Biotherapeutics, Inc. (ATRA) vs Neuraxis, Inc. (NRXS)
- Atara Biotherapeutics, Inc. ATRA 9.18 −4.87%
- Neuraxis, Inc. NRXS 7.70 −0.52%
Atara Biotherapeutics, Inc. and Neuraxis, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Neuraxis, Inc. are of similar size ($97.2M and $96.9M). Neuraxis, Inc. grew revenue faster over the last twelve months: 65.2% against −96.7%. Neuraxis, Inc. has the higher net margin (−159.0% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Neuraxis, Inc. leads on 9 and Atara Biotherapeutics, Inc. on 5.
Valuation
Profitability
| Metric | ATRA | NRXS | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 85.56% | 65.16% |
| Operating margin | (229.67%) | (144.51%) | 0.00% |
| Net margin | (269.42%) | (159.01%) | 0.00% |
| Free cash flow margin | (353.49%) | (106.10%) | 0.00% |
| Return on equity | 46.33% | (153.96%) | (56.36%) |
| Return on assets | (57.62%) | (98.96%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack